Lipidated immune response modifier compound compositions, formulations, and methods
The compound N-(4-{[4-amino-2-butyl-1H-imidazo[4,5-c]quinolin-1-yl]oxy}butyl)octadecanamide is a useful drug compound for enhancing immune response and can be used, for example, as a vaccine adjuvant and a cancer treatment.
1. A method of treating a viral, bacterial, fungal, or parasitic infection in an animal comprising administering an effective amount of a compound having the formula N-(4-{[4-amino-2-butyl-1H-imidazo[4,5-c]quinolin-1-yl]oxy}butyl)octadecanamide, or a pharmaceutically acceptable salt thereof, to the animal.
2. The method of claim 1 , which treats a viral infection in an animal.
3. The method of claim 1 , which treats a bacterial infection in an animal.
4. The method of claim 1 , which treats a fungal infection in an animal.
5. The method of claim 1 , which treats a parasitic infection in an animal.
6. The method of claim 1 , wherein the compound is co-delivered with a vaccine.
7. The method of claim 1 , wherein the treatment is a therapeutic or prophylactic treatment.
8. The method of claim 1 , wherein the treatment is a therapeutic treatment.
9. The method of claim 1 , wherein the treatment is a prophylactic treatment.
10. The method of claim 1 , wherein an antigen is co-delivered with the compound.
11. The method of claim 10 , wherein the antigen is a vaccine.
12. The method of claim 10 , wherein the antigen is co-delivered with the compound as an admixture in a pharmaceutical composition.